November 21, 2026
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

WHO Condemns US-Funded Hepatitis B Vaccine Trial in Guinea-Bissau as “Unethical”

February 16, 2026

The World Health Organization (WHO) has criticized a US-funded hepatitis B vaccine trial in Guinea-Bissau, calling it "unethical" for proposing to delay life-saving vaccination for thousands of newborns.

The study, led by Danish researchers and funded by the US Health Department, aimed to give one group of babies the hepatitis B vaccine at birth while postponing vaccination for another group until six weeks old. The WHO said this approach exposed infants to “potentially irreversible harm,” given that the birth-dose vaccine is a proven public health intervention with decades of safe use in more than 115 countries.

“Hepatitis B vaccination at birth prevents mother-to-child transmission in 70–95% of cases,” the WHO said. Infection at birth is the most common route to lifelong infection, with 90% of infected newborns becoming chronic carriers.

Guinea-Bissau currently administers the vaccine at six weeks, but authorities plan to roll out the birth-dose nationwide by 2028, in line with global standards. The WHO stressed that the trial could have accelerated this rollout but criticized the study’s scientific justification, ethical safeguards, and alignment with established research standards.

The trial, which was set to involve 14,000 newborns, was suspended last month after public outrage. Critics questioned why babies in Africa were being used for a study that would withhold a proven life-saving intervention.

The US health department overseeing the study is headed by Robert F. Kennedy Jr., who has previously raised doubts about vaccines despite publicly stating that he and his children have been vaccinated. Two months ago, a panel appointed by Kennedy voted to stop recommending hepatitis B vaccination for all US newborns, raising further ethical concerns.

The WHO reiterated that withholding a proven vaccine in a clinical trial is only acceptable when no effective treatment exists. For hepatitis B, the birth-dose vaccine is a critical, life-saving measure.

US, Venezuela Seal Military Cooperation Deal as Hegseth Visits Caracas

3 days ago

US Lawmakers Warn Sanctions on Rwanda Could Undermine Trump’s DRC Peace Deal

3 days ago

Carney, Trump Meet in China as Canada, US Seek Trade Deal

3 days ago

Museveni, Suluhu Agree to Fast-Track EACOP, SGR Projects

3 days ago

Sudan Court Sentences RSF Leader Hemedti, Brother and 11 Others to Death

3 days ago

Sam Mugumya, Two Others Charged with Security, Treachery Offences over Alleged ADF Links

Uganda Registers 34.9 Million Citizens, Cuts Passport Processing to Five Days

Xi and Trump Share Surprise Embrace as US President Arrives in China

Uganda Airlines Launches Daily Kigali Flights, Expands Network to 18 Destinations

Museveni, Dangote Discuss Oil Refining, Fertiliser Production and Mining Investments

Xi, Putin Discuss Global Security and Multipolar World Ahead of Trump Talks

UEFA Leaders Endorse French FA Chief Diallo for FIFA Presidency

5 days ago
US Embassies Issue Europe-Wide Security Alert Ahead of Christmas Season

5 days ago
Putin-Xi-Trump Meeting Agenda Revealed Ahead of Shenzhen Summit

5 days ago
Robert Pattinson Takes Over from Daniel Craig as James Bond

5 days ago
Uganda Warns Against Forged Documents in Citizenship Applications

5 days ago
Trump Says He May Meet North Korea’s Kim Jong Un During China Trip

5 days ago
Uganda Hands Over Conventional Weapons’ Chairmanship to Switzerland as Seventh Review Conference Opens in Geneva

5 days ago
FULL LIST: Tems, Asake, Davido, Wizkid and Ayra Starr Lead African Nominations in 2027 Grammy Nominations

5 days ago
South Africa Investigates 17 Deaths in Two Separate Mass Shootings

5 days ago
Romelu Lukaku Retires from International Football After 94 Goals for Belgium

5 days ago
King Oyo Foundation Outlines Plans to Preserve Late Monarch’s Legacy

5 days ago
AU Chief Urges African Leaders to Turn Youth Charter Promises into Jobs

5 days ago

Inside NRM’s 2031 Strategic Roadmap as Party Moves to Digitalise Its Register

1 month ago

Kabugho Marylin Joins Race as Battle for National Women’s Council Top Seat Intensifies

3 months ago

Who Will Lead Uganda’s Women’s Council? 4 Candidates Enter Heated Race

3 months ago

“Bring Home a Bumper Harvest!” Namyalo Dispatches ONC Coordinators To Sweep LC Polls For NRM

4 months ago

UG Diplomat is an independent digital news and media platform dedicated to comprehensive coverage of national politics, regional diplomacy, international relations, geopolitics, defense, and business. Published under Currentarc Media Ltd, we provide authoritative analysis, breaking news, and in-depth reporting on the diplomatic and economic developments shaping East Africa and the global arena.

COMPANY

Contact Us

Privacy Policy

Terms and Conditions

CONTACT INFORMATION

info@ugdiplomat.com

+256774552385

Copyright © 2026 UG Diplomat -Product of CURRENTARC MEDIA